• Skip to content
  • Skip to footer
American Antitrust Institute

American Antitrust Institute

Promoting competition that protects consumers, businesses, and society.

  • Impact
  • Our Work
    • Latest
    • Research, Education, Advocacy
      • Amicus Briefs
      • Economic & Policy Analysis
      • Film & Video
      • From the Advisory Board
      • Grant Research
      • Legal Analysis
      • Podcasts
      • Public Commentary & Testimony
      • Reports
    • Issues
      • Airlines
      • Banking & Finance
      • Digital Technology
      • Energy
      • Food & Agriculture
      • Health & Pharmaceuticals
      • Innovation
      • Intellectual Property
      • International
      • Labor
      • Media & Communications
      • Retail & Distribution
      • Transportation
  • About AAI
    • Mission & History
    • Our People
    • Careers & Internships
    • Awards
    • AAI Appellate Project
    • AAI Public Service Fellowship
  • News & Events
    • News
      • Latest News
      • Podcasts
      • Social Feed
    • Events
      • All Events
      • CLE Credits
  • Support
    • Independence and Transparency
    • Sponsorships
    • Cy Pres Grants
    • Sherman Society
  • Contact Us
Home /  Our Work  / ...
August 27, 2012 | Richard Brunell, Thomas Greaney, Barak Richman, Christopher Sagers, Peter C. Carstensen, Ted Frech, Matt Cantor
Health & Pharmaceuticals, Mergers, Exemptions & Immunities

AAI Supports FTC in Supreme Court (FTC v. Phoebe Putney)

The AAI filed an amicus brief in the Supreme Court urging the Court to reverse an Eleventh Circuit ruling that dismissed, on state action grounds, an FTC challenge to a hospital merger creating a virtual monopoly in Albany Georgia. The brief asked the Court to disclaim the Eleventh Circuit’s permissive test for determining when a state adopts a “clearly articulated and affirmatively expressed policy” to displace competition, arguing that the Circuit’s test is not only inconsistent with federal antitrust policy, but with federalism principles as well.

The brief was written by AAI Director of Legal Advocacy Rick Brunell, with assistance from AAI Advisory Board Members Tim Greaney, Barak Richman, Chris Sagers, Ted Frech, and Peter Carstensen and Matt Cantor (Constantine Cannon).

AAI Amicus Brief

Related Work

Amicus Briefs

AAI Urges Ninth Circuit Not to Second Guess Jury Verdicts Defining Single-Brand Product Market and Awarding Half-Billion Dollars in Treble Damages (Innovative Health, LLC v. Biosense Webster, LLC)

June 1, 2026
Health & Pharmaceuticals , Section 1 of the Sherman Act , Section 2 of the Sherman Act , Section 7 of the Clayton Act
Public Comments and Testimony

AAI Urges FTC to Vigorously Defend Rule Revising Merger Filing Form

May 20, 2026 | David O. Fisher
Comments and Testimony , FTC , Mergers
Public Comments and Testimony

“Don’t Let the Fox Guard the Hen House”: AAI Files Comments Urging FTC to Close Loopholes in Express Scripts PBM Settlement

March 18, 2026
FTC , Section 5 of the FTC Act , Health & Pharmaceuticals , Competition Policy , Remedies
Amicus Briefs

AAI Tells Third Circuit to Be Practical About Substantial Foreclosure in Exclusive Dealing Cases (Reading Hospital v. Hill-Rom Holdings)

February 10, 2026 | Randy Stutz, Mark S. Hegedus, Jamie Crooks, Mike Goldberg
Health & Pharmaceuticals , Monopolies , Private Enforcement
Make a donation

Footer

About AAI

  • Mission and History
  • Our People
  • Awards
  • Careers & Internships

Our Work

News & Events

Support AAI

Contact Us

Join Our Mailing List

Terms of use
© 2024 American Antitrust Institute. All rights reserved.